JP Morgan Chase
NEPH icon

JP Morgan Chase’s Nephros NEPH Stock Holding History

JP Morgan Chase’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13
Closed -$22 – 7456
2025
Q1 		$22 Sell
13
-2
-13% -$3 ﹤0.01% 7108
2024
Q4 		$22 Sell
15
-206
-93% -$314 ﹤0.01% 7256
2024
Q3 		$378 Sell
221
-1
-0.5% -$2 ﹤0.01% 6826
2024
Q2 		$469 Buy
222
+1
+0.5% +$2 ﹤0.01% 6694
2024
Q1 		$484 Buy
221
+211
+2,110% +$669 ﹤0.01% 6722
2023
Q4 		$35 Buy
10
+2
+25% +$4 ﹤0.01% 7254
2023
Q3 		$12 Buy
+8
New +$12 ﹤0.01% 7266
2020
Q4 		– Sell
-3
Closed – – 5829
2020
Q3 		$0 Hold
3
– – ﹤0.01% 5667
2020
Q2 		$0 Buy
+3
New +$24 ﹤0.01% 5587

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's NEPH Position: Q2 2025 in Review

JP Morgan Chase sold out of Nephros (NEPH) in Q2 2025, closing a stake of 13 shares — an estimated $22 sold.

JP Morgan Chase first reported a position in NEPH in Q2 2020 and held it in 9 quarters. The position peaked at $484 in Q1 2024. 21 funds tracked by Wall St. Rank hold NEPH as of Q2 2025.

  • JP Morgan Chase reported no remaining Nephros position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 13 Nephros shares in Q2 2025, an estimated $22.
  • JP Morgan Chase first reported a position in Nephros in Q2 2020 and held it in 9 quarters.
  • JP Morgan Chase's Nephros position peaked at $484 in Q1 2024.
  • 21 funds tracked by Wall St. Rank held Nephros as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.